BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34896114)

  • 21. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
    Saraiva J; Nobre RJ; Pereira de Almeida L
    J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle.
    Zheng H; Qiao C; Wang CH; Li J; Li J; Yuan Z; Zhang C; Xiao X
    Hum Gene Ther; 2010 Jan; 21(1):87-97. PubMed ID: 19719401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.
    Bevan AK; Duque S; Foust KD; Morales PR; Braun L; Schmelzer L; Chan CM; McCrate M; Chicoine LG; Coley BD; Porensky PN; Kolb SJ; Mendell JR; Burghes AH; Kaspar BK
    Mol Ther; 2011 Nov; 19(11):1971-80. PubMed ID: 21811247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord.
    Hendriks WT; Ruitenberg MJ; Blits B; Boer GJ; Verhaagen J
    Prog Brain Res; 2004; 146():451-76. PubMed ID: 14699980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury.
    Kwon BK; Liu J; Lam C; Plunet W; Oschipok LW; Hauswirth W; Di Polo A; Blesch A; Tetzlaff W
    Spine (Phila Pa 1976); 2007 May; 32(11):1164-73. PubMed ID: 17495772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials.
    Hardcastle N; Boulis NM; Federici T
    Expert Opin Biol Ther; 2018 Mar; 18(3):293-307. PubMed ID: 29249183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adeno-associated virus-mediated human acidic fibroblast growth factor expression promotes functional recovery of spinal cord-contused rats.
    Huang WC; Kuo HS; Tsai MJ; Ma H; Chiu CW; Huang MC; Yang LH; Chang PT; Lin YL; Kuo WC; Lee MJ; Liu JC; Cheng H
    J Gene Med; 2011 May; 13(5):283-9. PubMed ID: 21557400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The advent of AAV9 expands applications for brain and spinal cord gene delivery.
    Dayton RD; Wang DB; Klein RL
    Expert Opin Biol Ther; 2012 Jun; 12(6):757-66. PubMed ID: 22519910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
    Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
    Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.
    Bey K; Ciron C; Dubreil L; Deniaud J; Ledevin M; Cristini J; Blouin V; Aubourg P; Colle MA
    Gene Ther; 2017 May; 24(5):325-332. PubMed ID: 28425480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems.
    Abdellatif AA; Pelt JL; Benton RL; Howard RM; Tsoulfas P; Ping P; Xu XM; Whittemore SR
    J Neurosci Res; 2006 Aug; 84(3):553-67. PubMed ID: 16786574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration.
    Gray SJ; Choi VW; Asokan A; Haberman RA; McCown TJ; Samulski RJ
    Curr Protoc Neurosci; 2011 Oct; Chapter 4():Unit 4.17. PubMed ID: 21971848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle injection of AAV-NT3 promotes anatomical reorganization of CST axons and improves behavioral outcome following SCI.
    Fortun J; Puzis R; Pearse DD; Gage FH; Bunge MB
    J Neurotrauma; 2009 Jul; 26(7):941-53. PubMed ID: 19275471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury.
    Hirai T; Enomoto M; Kaburagi H; Sotome S; Yoshida-Tanaka K; Ukegawa M; Kuwahara H; Yamamoto M; Tajiri M; Miyata H; Hirai Y; Tominaga M; Shinomiya K; Mizusawa H; Okawa A; Yokota T
    Mol Ther; 2014 Feb; 22(2):409-419. PubMed ID: 24322332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
    Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
    Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
    Chamberlain K; Riyad JM; Weber T
    Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice.
    Hirai T; Enomoto M; Machida A; Yamamoto M; Kuwahara H; Tajiri M; Hirai Y; Sotome S; Mizusawa H; Shinomiya K; Okawa A; Yokota T
    Hum Gene Ther Methods; 2012 Apr; 23(2):119-27. PubMed ID: 22583159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function.
    Blits B; Oudega M; Boer GJ; Bartlett Bunge M; Verhaagen J
    Neuroscience; 2003; 118(1):271-81. PubMed ID: 12676157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain.
    Liu J; Wolfe D; Hao S; Huang S; Glorioso JC; Mata M; Fink DJ
    Mol Ther; 2004 Jul; 10(1):57-66. PubMed ID: 15233942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical AAV-CNTF Gene Therapy Combined with Intraspinal Mesenchymal Precursor Cell Transplantation Promotes Functional and Morphological Outcomes after Spinal Cord Injury in Adult Rats.
    Hodgetts SI; Yoon JH; Fogliani A; Akinpelu EA; Baron-Heeris D; Houwers IGJ; Wheeler LPG; Majda BT; Santhakumar S; Lovett SJ; Duce E; Pollett MA; Wiseman TM; Fehily B; Harvey AR
    Neural Plast; 2018; 2018():9828725. PubMed ID: 30245710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.